News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Alexion
NEWS
JOBS
IN THE PRESS
NEWS
Business
Former Baxalta CEO to Helm Struggling Alexion
March 27, 2017
·
3 min read
Job Trends
Embattled Alexion Pink Slips 200+ Staffers in Restructuring
March 14, 2017
·
3 min read
Pharm Country
Alexion Who? Buy These 4 Biotech Stocks Instead
February 20, 2017
·
1 min read
Deals
Alexion’s Bloated Blockbuster Deal Still Haunts
February 17, 2017
·
1 min read
Genetown
Why Red-Hot Alexion Is Only Suitable For Risk Takers Now
January 12, 2017
·
1 min read
Pharm Country
Why Alexion Is Overvalued
January 6, 2017
·
1 min read
Business
Alexion Admits Senior Management Pressured Staff to Boost Soliris Sales
January 5, 2017
·
2 min read
Drug Development
After Fraud Probe, Alexion Reports Failed Soliris Trial
December 22, 2016
·
2 min read
Business
After CEO Ouster, Interim Alexion Boss Says “We Need To Move On”
December 13, 2016
·
1 min read
AWARDS
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program
September 22, 2025
·
4 min read
Press Releases
JCR Pharmaceuticals Enters License Agreement with Alexion for Proprietary JUST-AAV Capsids to be Used in the Development of Genomic Medicines
July 8, 2025
·
5 min read
Press Releases
Alexion, AstraZeneca Rare Disease reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for Koselugo (selumetinib) for the treatment of paediatric patients with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)
December 18, 2024
·
5 min read
Press Releases
KOSELUGO® (selumetinib) Showed Significant and Clinically Meaningful Improvement in Objective Response Rate Versus Placebo in Adults With Neurofibromatosis Type 1 who Have Symptomatic, Inoperable Plexiform Neurofibromas in Global Phase 3 KOMET Trial
November 12, 2024
·
14 min read
Press Releases
Monopar Announces Agreement with Alexion, AstraZeneca Rare Disease For Late-Stage Wilson Disease Drug Candidate
October 25, 2024
·
8 min read
Business
AstraZeneca demonstrates commitment to patients living with amyloidosis at the 2024 International Symposium on Amyloidosis (ISA)
May 23, 2024
·
13 min read
Business
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
March 19, 2024
·
4 min read
Drug Development
Long-term ALPHA Phase III trial data showed danicopan as add-on to ULTOMIRIS® or SOLIRIS® sustained clinical improvements in subset of patients with PNH experiencing clinically significant extravascular hemolysis
December 10, 2023
·
29 min read
Business
Verge Genomics Announces Artificial Intelligence-Enabled Drug Discovery Collaboration with Alexion for Rare Neurodegenerative and Neuromuscular Diseases
September 8, 2023
·
3 min read
BioCapital
Alexion advances commitment to transform patient outcomes in rare neurological diseases at AAN 2023
March 2, 2023
·
21 min read
